PLASMA DELTA-9-TETRAHYDROCANNABINOL CONCENTRATIONS AND CLINICAL EFFECTS AFTER ORAL AND INTRAVENOUS ADMINISTRATION AND SMOKING

被引：352

作者：

OHLSSON, A

LINDGREN, JE

WAHLEN, A

AGURELL, S

HOLLISTER, LE

GILLESPIE, HK

机构：

[1] VET ADM HOSP,MED CTR,PALO ALTO,CA 94304

[2] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN

[3] ASTRA LAKEMEDEL AB,S-15185 SODERTALJE,SWEDEN

来源：

关键词：

D O I：

10.1038/clpt.1980.181

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：409 / 416

页数：8

共 21 条

[1] AGURELL S, 1976, PHARM MARIHUANA, P49
[2] AGURELL S, 1979, MARIHUANA BIOL EFFEC, P3
[3] DOMINO EF, 1974, CLIN PHARMACOL THER, V15, P514
[4] STABILITY OF TETRAHYDROCANNABINOLS .2.
GARRETT, ER
GOUYETTE, AJ
ROSEBOOM, H
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (01) : 27 - 32
[5] PHARMACOKINETICS OF DELTA-9-TETRAHYDROCANNABINOL IN DOGS
GARRETT, ER
HUNT, CA
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (03) : 395 - 407
[6] HOLLISTER LE, 1973, CLIN PHARMACOL THER, V14, P353
[7] STRUCTURE-ACTIVITY-RELATIONSHIPS IN MAN OF CANNABIS CONSTITUENTS, AND HOMOLOGS AND METABOLITES OF DELTA-9-TETRAHYDROCANNABINOL
HOLLISTER, LE
[J]. PHARMACOLOGY, 1974, 11 (01) : 3 - 11
[8] HOLLISTER LE, 1975, CLIN PHARMACOL THER, V18, P80
[9] HOSKO MJ, 1973, CLIN PHARMACOL THER, V14, P344
[10] DELTA-9-TETRAHYDROCANNABINOL - TEMPORAL CORRELATION OF PSYCHOLOGIC EFFECTS AND BLOOD LEVELS AFTER VARIOUS ROUTES OF ADMINISTRATION
LEMBERGER, L
WEISS, JL
WATANABE, AM
WYATT, RJ
CARDON, PV
GALANTER, IM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (13) : 685 - +